Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;35(12):e15845.
doi: 10.1111/dth.15845. Epub 2022 Oct 18.

Efficacy and safety of baricitinib in patients with refractory alopecia areata

Yuqian Wang  1 , Taoming Liu  1 , Sheng Li  1 , Shunli Tang  1 , Peiyi Lin  1 , Yuwei Ding  1 , Qingmiao Sun  1 , Dingxian Zhu  1 , Jianjun Qiao  1 , Hong Fang  1
Affiliations
Comment

Efficacy and safety of baricitinib in patients with refractory alopecia areata

Yuqian Wang et al. Dermatol Ther. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to disclose in relation to the present study.

Figures

FIGURE 1
FIGURE 1
Clinical images of the “patient 2” and “patient 6” at 0–8‐12 and 20th weeks of follow‐up in the pictures 1–2–3‐4, respectively (a. Occipital view, b. Right parietal view, c. Left parietal view, and d. Posterior view)
See this image and copyright information in PMC

Comment on

References

    1. Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1‐12. - PubMed
    1. Meah N, Wall D, York K, et al. The alopecia Areata consensus of experts (ACE) study: results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020;83(1):123‐130. - PubMed
    1. Pourang A, Mesinkovska NA. New and emerging therapies for alopecia Areata. Drugs. 2020;80(7):635‐646. - PubMed
    1. Ismail FF, Sinclair R. JAK inhibition in the treatment of alopecia areata: a promising new dawn? Expert Rev Clin Pharmacol. 2020;13(1):43‐51. - PubMed
    1. King B, Ohyama M, Kwon O, et al. Two phase 3 trials of Baricitinib for alopecia Areata. N Engl J Med. 2022;386(18):1687‐1699. - PubMed

Supplementary concepts